Governance

Executive management team

Hiroshi Uchida – Magellan President and CEO

James Whelan – POC and Microbiology

Adrian Bunce – Immunoassay/Automated Solutions

Pam Gornall – Magellan CFO

Jeffrey M. Cohen – Vice President, Information Technologies

Debra Manning Dutko – Director of Human Resources

Board of directors

Herbert Hooper, PhD – Magellan Chairman, Managing General Partner of Ampersand Ventures (private equity investments)

Michael F. Bigham – Abingworth Management Director, responsible for the Boston office (venture capital firm)

Heiner Dreismann, PhD – Former President and CEO, Roche Molecular Diagnostics (PCR-based molecular diagnostic tests)

Peter H. Glick – Ampersand Ventures General Partner (private equity investments)

Laurence R. McCarthy, PhD – Former President and CEO of Focus Diagnostics, Inc., (developer of novel assays and diagnostic-testing services)

Daniel R. Omstead, Eng.ScD – President and CEO, Hambrecht & Quist Capital Management (registered investment advisor)

Hiroshi Uchida, PhD – Magellan President and CEO

Michael E. Woehler, PhD – President and CEO, Medifacts International (contract clinical-trial services to the pharmaceutical, biotech, and medical-device industries